Germanium-68 (GE-68) can be delivered for a long time because about 270 days is required to reduce to half of its initial value. The Korea Atomic Energy Research Institute (KAERI) has produced GE-68 using RFT-30 cyclotron, a proton accelerator for radioisotope production. The first batch of GE-68 produced by KAERI will go to Sanders Medical, a U.S. medical device company.
Countries like the U.S., Russia and Germany control more than 90 percent of the global GE-68 market. However, securing a new supplier has become essential because of its growing demands. For its initial shipment, KAERI will export about five millicuries (mCi) worth about 10 million won ($7,855) to create a calibration source product. The institute aims to produce 100 mCi in 2022.
"Germanium-68 is a high-value-added radioactive isotope that can be used to develop new drugs," Jung Kyung-il, head of the Korea Association for Radiation Application, said, adding the export of Germanium-68 has a significant meaning for the development of the domestic radioactive isotope sector.
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.